Advertisement

New Leadership Elected to the American Society of Hematology


Advertisement
Get Permission

The American Society of Hematology (ASH) recently announced the election of four new members to its Executive Committee for terms beginning after the 2022 ASH Annual Meeting & Exposition in December in New Orleans.

Belinda R. Avalos, MD

Belinda R. Avalos, MD

Joseph Mikhael, MD, MEd

Joseph Mikhael, MD, MEd

Jane N. Winter, MD

Jane N. Winter, MD

Belinda R. Avalos, MD, will serve a 1-year term as Vice President, followed by successive terms as President-Elect and President. Joseph Mikhael, MD, MEd, will serve a 4-year term as Treasurer, and Christopher R. Flowers, MD, MSc, and Charlotte M. Niemeyer, MD, MA, will each serve 4-year terms as Councillors.

“Drs. Avalos, Mikhael, Flowers, and Niemeyer have demonstrated immense dedication to ASH, its members, and the field of hematology. Together, they represent the future of the Society and the field,” said current ASH President, Jane N. Winter, MD, of the Robert H. Lurie Comprehensive Cancer Center at Northwestern University.

Vice President-Elect

Dr. Avalos is Professor of Medicine and a Senior Advisor to the President of Atrium Health Levine Cancer Institute. As a physician-scientist, she has made significant research contributions in the areas of leukemogenesis, congenital neutropenia, transplantation, and cellular therapy.

Treasurer-Elect

Dr. Mikhael is Professor in the Applied Cancer Research and Drug Discovery Division at the Translational Genomics Research Institute (TGen), an affiliate of City of Hope Cancer Center. He is also Chair of the Diversity, Equity, and Inclusion Council at TGen and Chief Medical Officer of the International Myeloma Foundation. Additionally, he serves as a consultant hematologist and Director of Myeloma Research at the HonorHealth Research Institute.

Councillor-Elect

Dr. Flowers is Division Head ad interim of the Division of Cancer Medicine and Professor and Chair of the Department of Lymphoma and Myeloma at The University of Texas MD Anderson Cancer Center. His research interests include clinical lymphoma and evidence-based clinical practice guidelines development.

International Councillor-Elect

Dr. Niemeyer is Professor of Pediatrics and Director of the Division of Pediatric Hematology and Oncology in the Department of Pediatrics at Freiburg University Medical Center. Her research interests include diagnosis and therapy for bone marrow failure disorders and pediatric myelodysplastic syndromes. 


Advertisement

Advertisement



Advertisement